Physician profile
Ethan K Alexander
NPI 1932638475
$968.81
in general payments reported to CMS, 2019-2025
8 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $28.85 · 2022: $47.72 · 2023: $16.34 · 2024: $66.14 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaneka Medical America LLC | $361.22 | 2019 | |
| Amgen INC. | $247.82 | 2025 | Repatha |
| Regeneron Healthcare Solutions, INC. | $147.08 | 2022-2025 | Evkeeza |
| Novartis Pharmaceuticals Corporation | $106.57 | 2024-2025 | |
| Novo Nordisk INC | $38.73 | 2022-2023 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.85 | 2020 | |
| Abbott Laboratories | $23.16 | 2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $15.38 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.